✦ LIBER ✦

A specific VEGF-R tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in ErbB-2 overexpressing breast cancer cells

✍ Scribed by Elizabeth Min Hui Kim; Catherine Lobocki; Linda Dubay; Vijay Mittal

Book ID: 113678121
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 55 KB
Volume: 205
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2007.06.236

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A specific vascular endothelial growth f

A specific vascular endothelial growth factor receptor tyrosine kinase inhibitor enhances the antiproliferative effect of trastuzumab in human epidermal growth factor receptor 2 overexpressing breast cancer cell lines

✍ Elizabeth M.H. Kim; Catherine Lobocki; Linda Dubay; Vijay K. Mittal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 680 KB

Combining lapatinib (GW572016), a small

Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells

✍ Xia, Wenle; Gerard, Catherine M; Liu, Leihua; Baudson, Nathalie M; Ory, Thierry 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 235 KB

Lapatinib, a Dual ErbB-1/ErbB-2 Kinase I

Lapatinib, a Dual ErbB-1/ErbB-2 Kinase Inhibitor, in the Treatment of HER2-Overexpressing Locally Advanced and Metastatic Breast Cancer

✍ Susan R. Peck; Joyce A. O'Shaughnessy 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 95 KB

Targeting endothelin A receptor enhances

Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells

✍ Jeanett Fischgräbe; Martin Götte; Katharina Michels; Ludwig Kiesel; Pia Wülfing 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev

(R)-FTY720 methyl ether is a specific sp

(R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cells

✍ Keng Gat Lim; Chaode Sun; Robert Bittman; Nigel J. Pyne; Susan Pyne 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 645 KB

554 POSTER The mTOR effector p70 S6 kina

554 POSTER The mTOR effector p70 S6 kinase 1 (S6K1): a specific biomarker for the biological effects of the dual HER1/HER2 kinase inhibitor Lapatinib (GW572016) in HER2-overexpressing breast cancer cells

✍ A. Vazquez-Martin; R. Colomer; J.A. Menendez 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB